Covered recipient · General Payments record
COLBY LARS PRESLEY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2021–2024
$2,689.61
- Reported across 49 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,285.84 | 23 |
| Education | $79.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $331.41 | 4 |
| Dermavant Sciences, Inc. | $270.40 | 2 |
| GENZYME CORPORATION | $256.78 | 6 |
| Arcutis Biotherapeutics, Inc. | $147.92 | 2 |
| E.R. Squibb & Sons, L.L.C. | $128.81 | 1 |
| Amgen Inc. | $116.58 | 3 |
| ABBVIE INC. | $94.21 | 5 |
| Incyte Corporation | $19.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.53 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105310670 | CMS |
| ABBVIE INC. | $18.79 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105310674 | CMS |
| ABBVIE INC. | $18.25 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105310678 | CMS |
| ABBVIE INC. | $19.74 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105310681 | CMS |
| ABBVIE INC. | $21.90 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105310685 | CMS |
| Amgen Inc. | $19.00 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117356920 | CMS |
| Amgen Inc. | $20.76 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117356922 | CMS |
| Amgen Inc. | $76.82 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117356924 | CMS |
| Arcutis Biotherapeutics, Inc. | $38.46 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121041050 | CMS |
| Arcutis Biotherapeutics, Inc. | $109.46 | 09/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121041052 | CMS |
| Dermavant Sciences, Inc. | $99.01 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127919949 | CMS |
| Dermavant Sciences, Inc. | $171.39 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127919953 | CMS |
| E.R. Squibb & Sons, L.L.C. | $128.81 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101398619 | CMS |
| GENZYME CORPORATION | $23.08 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139798988 | CMS |
| GENZYME CORPORATION | $23.08 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139798992 | CMS |
| GENZYME CORPORATION | $26.05 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139799078 | CMS |
| GENZYME CORPORATION | $139.86 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139799074 | CMS |
| GENZYME CORPORATION | $22.49 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139799096 | CMS |
| GENZYME CORPORATION | $22.22 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139799102 | CMS |
| Incyte Corporation | $19.72 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141276218 | CMS |
| Janssen Biotech, Inc. | $99.75 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078549142 | CMS |
| Janssen Biotech, Inc. | $130.01 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078549462 | CMS |
| Janssen Biotech, Inc. | $79.99 | 03/18/2024 | Education | Undisputed | 01/23/2026 | 1078549279 | CMS |
| Janssen Biotech, Inc. | $21.66 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078549484 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.